Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06382636 · ClinicalTrials.gov registry record · NA

Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes

A NA study of Prenatal Disorder, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
3
Study locations

NCT06382636 is a NA study of Prenatal Disorder that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 600 participants. The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06382636, a NA study of Prenatal Disorder, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
3
Study locations

Study Summary

The goal of this study is to ensure that pregnant patients have the resources and support needed to access Prenatal Screening \& Diagnostic Testing (PS\&D) in an informed and evidence-based fashion by developing an innovative digital tool to support patients' decision-making and contributing fundamental knowledge to advance science in a way that promotes patients' access to new prenatal applications of genomic science and technology. Our central hypothesis is that, by focusing on patient engagement as a key driver to improve patient outcomes, the use of an evidence-based artificial-intelligence (AI) powered patient engagement tool will increase patients' ability to seek information and structure a decision-making process that, in turn, increases informed decisions about PS\&D and decreases decisional conflict associated with those decisions. Using data from NEST (Ensuring Patients Informed Access to NIPT \[non-invasive prenatal testing\]), the investigators designed the next iteration of NEST, a point-of care shared decision-making tool powered by artificial intelligence (AI) to provide a personalized and dynamic decision support tool: Obstetric Prenatal Genetic Testing Engagement Solution (OPUS). OPUS is an AI-enabled healthcare chatbot (a computer program capable of processing and simulating human conversation) that provides patients with personalized information and decision-making support at different stages of the PS\&D pathway. It functions using a series of questions contained in the NEST with a branching logic sequence of questions and answers based on the responses to and from the patient, using a conversational and adaptable interaction. It also contains nested tiers of information, ranging from introductory to detailed information about patient engagement, health literacy, the different PS\&D options, and resources to learn about insurance coverage for PS\&D. OPUS was designed to be accessed by patients with different technological resources and preferen

Conditions Studied

Interventions

  • BEHAVIORAL Standard Care
  • BEHAVIORAL Obstetric Prenatal Genetic Testing Engagement Solution (OPUS) AI Chatbot

Study Locations (3)

Ohio

  • Neighborhood Family Practice - Cleveland
  • MetroHealth Medical Center - Cleveland
  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2024-05-06
Est. Completion 2027-02-28
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT06382636

The ClinicalTrials.gov registry entry for NCT06382636 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prenatal Disorder appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.

NCT06382636 reports 3 study locations spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06382636 about?

NCT06382636 is a clinical study titled "Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes". The goal of this study is to ensure that pregnant patients have the resources and support needed to access Prenatal Screening \& Diagnostic Testing (PS\&D) in an informed and evidence-based fashion by developing an innovative digital tool to support patients' decision-making and contributing fundame...

What is the current status of trial NCT06382636?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-05-06. Estimated completion is 2027-02-28.

What conditions does trial NCT06382636 study?

This clinical trial studies the following conditions: Prenatal Disorder.

What interventions are being tested in trial NCT06382636?

The interventions under investigation include: Standard Care (BEHAVIORAL), Obstetric Prenatal Genetic Testing Engagement Solution (OPUS) AI Chatbot (BEHAVIORAL).

Who is sponsoring clinical trial NCT06382636?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06382636 being conducted?

This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prenatal Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.